IBDEI0ZE ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16308,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16308,1,3,0)
 ;;=3^Lupus Erythematosus,Discoid
 ;;^UTILITY(U,$J,358.3,16308,1,4,0)
 ;;=4^L93.0
 ;;^UTILITY(U,$J,358.3,16308,2)
 ;;=^5009467
 ;;^UTILITY(U,$J,358.3,16309,0)
 ;;=L93.1^^88^845^56
 ;;^UTILITY(U,$J,358.3,16309,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16309,1,3,0)
 ;;=3^Lupus Erythematosus,Subacute Cutaneous
 ;;^UTILITY(U,$J,358.3,16309,1,4,0)
 ;;=4^L93.1
 ;;^UTILITY(U,$J,358.3,16309,2)
 ;;=^5009468
 ;;^UTILITY(U,$J,358.3,16310,0)
 ;;=L93.2^^88^845^55
 ;;^UTILITY(U,$J,358.3,16310,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16310,1,3,0)
 ;;=3^Lupus Erythematosus,Other
 ;;^UTILITY(U,$J,358.3,16310,1,4,0)
 ;;=4^L93.2
 ;;^UTILITY(U,$J,358.3,16310,2)
 ;;=^5009469
 ;;^UTILITY(U,$J,358.3,16311,0)
 ;;=L04.9^^88^845^60
 ;;^UTILITY(U,$J,358.3,16311,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16311,1,3,0)
 ;;=3^Lymphadenitis,Acute,Unspec
 ;;^UTILITY(U,$J,358.3,16311,1,4,0)
 ;;=4^L04.9
 ;;^UTILITY(U,$J,358.3,16311,2)
 ;;=^5009074
 ;;^UTILITY(U,$J,358.3,16312,0)
 ;;=R59.1^^88^845^57
 ;;^UTILITY(U,$J,358.3,16312,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16312,1,3,0)
 ;;=3^Lymph Nodes,Enlarged,Generalized
 ;;^UTILITY(U,$J,358.3,16312,1,4,0)
 ;;=4^R59.1
 ;;^UTILITY(U,$J,358.3,16312,2)
 ;;=^5019530
 ;;^UTILITY(U,$J,358.3,16313,0)
 ;;=R59.0^^88^845^58
 ;;^UTILITY(U,$J,358.3,16313,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16313,1,3,0)
 ;;=3^Lymph Nodes,Enlarged,Localized
 ;;^UTILITY(U,$J,358.3,16313,1,4,0)
 ;;=4^R59.0
 ;;^UTILITY(U,$J,358.3,16313,2)
 ;;=^5019529
 ;;^UTILITY(U,$J,358.3,16314,0)
 ;;=R59.9^^88^845^59
 ;;^UTILITY(U,$J,358.3,16314,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16314,1,3,0)
 ;;=3^Lymph Nodes,Enlarged,Unspec
 ;;^UTILITY(U,$J,358.3,16314,1,4,0)
 ;;=4^R59.9
 ;;^UTILITY(U,$J,358.3,16314,2)
 ;;=^5019531
 ;;^UTILITY(U,$J,358.3,16315,0)
 ;;=L60.9^^88^845^61
 ;;^UTILITY(U,$J,358.3,16315,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16315,1,3,0)
 ;;=3^Nail Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,16315,1,4,0)
 ;;=4^L60.9
 ;;^UTILITY(U,$J,358.3,16315,2)
 ;;=^5009240
 ;;^UTILITY(U,$J,358.3,16316,0)
 ;;=L60.3^^88^845^62
 ;;^UTILITY(U,$J,358.3,16316,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16316,1,3,0)
 ;;=3^Nail Dystrophy
 ;;^UTILITY(U,$J,358.3,16316,1,4,0)
 ;;=4^L60.3
 ;;^UTILITY(U,$J,358.3,16316,2)
 ;;=^5009236
 ;;^UTILITY(U,$J,358.3,16317,0)
 ;;=L60.0^^88^845^63
 ;;^UTILITY(U,$J,358.3,16317,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16317,1,3,0)
 ;;=3^Nail,Ingrowing
 ;;^UTILITY(U,$J,358.3,16317,1,4,0)
 ;;=4^L60.0
 ;;^UTILITY(U,$J,358.3,16317,2)
 ;;=^5009234
 ;;^UTILITY(U,$J,358.3,16318,0)
 ;;=L60.2^^88^845^70
 ;;^UTILITY(U,$J,358.3,16318,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16318,1,3,0)
 ;;=3^Onychogryphosis
 ;;^UTILITY(U,$J,358.3,16318,1,4,0)
 ;;=4^L60.2
 ;;^UTILITY(U,$J,358.3,16318,2)
 ;;=^5009235
 ;;^UTILITY(U,$J,358.3,16319,0)
 ;;=L97.109^^88^845^69
 ;;^UTILITY(U,$J,358.3,16319,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16319,1,3,0)
 ;;=3^Nonpressure Chr Ulcer of Thigh
 ;;^UTILITY(U,$J,358.3,16319,1,4,0)
 ;;=4^L97.109
 ;;^UTILITY(U,$J,358.3,16319,2)
 ;;=^5009484
 ;;^UTILITY(U,$J,358.3,16320,0)
 ;;=L97.209^^88^845^65
 ;;^UTILITY(U,$J,358.3,16320,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16320,1,3,0)
 ;;=3^Nonpressure Chr Ulcer of Calf
 ;;^UTILITY(U,$J,358.3,16320,1,4,0)
 ;;=4^L97.209
 ;;^UTILITY(U,$J,358.3,16320,2)
 ;;=^5009499
 ;;^UTILITY(U,$J,358.3,16321,0)
 ;;=L97.309^^88^845^64
 ;;^UTILITY(U,$J,358.3,16321,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16321,1,3,0)
 ;;=3^Nonpressure Chr Ulcer of Ankle
